Is the development of a new tuberculosis vaccine possible?

Abstract

Whereas federal expenditure in the United States on the development of an HIV/AIDS vaccine is approximately $250 million, only $25 million is spent on research and development for a malaria vaccine. It is not malaria but tuberculosis (TB) that is the poor relation. Government funds for a vaccine to fight this disease are in single figure millions. Stelan Kaufmann of the Max Planck Institute for Infection Biology examines obstacles in addition to funding that hinder the development of a new TB vaccine.